Goldman Sachs Group set a CHF 110 price objective on Swiss Re (VTX:SREN) in a research report released on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
A number of other research analysts also recently weighed in on the stock. Deutsche Bank reiterated a hold rating and issued a GBX 1,775 ($23.19) price objective on shares of in a research report on Wednesday, June 26th. UBS Group upgraded shares of to a neutral rating and upped their price objective for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research report on Thursday, June 20th. Credit Suisse Group reiterated a neutral rating and issued a $100.00 price objective on shares of Procter & Gamble in a research report on Tuesday, April 23rd. Royal Bank of Canada reiterated a sector perform rating and issued a GBX 485 ($6.34) price objective on shares of in a research report on Tuesday, July 9th. Finally, Barclays reissued an underweight rating and set a GBX 600 ($7.84) target price on shares of in a research note on Monday, July 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company’s stock. Swiss Re presently has a consensus rating of Buy and a consensus target price of CHF 105.67.
Swiss Re has a 1 year low of CHF 81.65 and a 1 year high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Article: How Buying a Call Option Works
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.